📣 VC round data is live. Check it out!

LifeStance Health Valuation Multiples

Discover LifeStance Health's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like IKS Health, Krishna Institute, Dallah Healthcare, Option Care Health and more.

LifeStance Health Overview

About LifeStance Health

LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The group y has a single operating and reportable segment of mental health services.


Founded

2021

HQ

United States

Employees

10.2K

Financials (LTM)

Revenue: $2B
EBITDA: $180M

EV

$3B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

LifeStance Health Financials

LifeStance Health reported last 12-month revenue of $2B and EBITDA of $180M.

In the same LTM period, LifeStance Health generated $502M in gross profit, $180M in EBITDA, and $30M in net income.

Revenue (LTM)


LifeStance Health P&L

In the most recent fiscal year, LifeStance Health reported revenue of $1B and EBITDA of $158M.

LifeStance Health is profitable as of last fiscal year, with gross margin of 32%, EBITDA margin of 11%, and net margin of 1%.

See analyst estimates for LifeStance Health
LTMLast FY202320242025202620272028
Revenue$2B$1B$1B$1B$1B
Gross Profit$502M$461M$302M$402M$461M
Gross Margin33%32%29%32%32%
EBITDA$180M$158M($105M)$40M$79M
EBITDA Margin12%11%(10%)3%6%
EBIT Margin3%2%(18%)(3%)2%
Net Profit$30M$10M($186M)($57M)$10M
Net Margin2%1%(18%)(5%)1%
Net Debt-$32M---

Financial data powered by Morningstar, Inc.

LifeStance Health Stock Performance

LifeStance Health has current market cap of $3B, and enterprise value of $3B.

Market Cap Evolution


LifeStance Health's stock price is $7.94.

LifeStance Health share price increased by 3.0% in the last 30 days, and by 53.7% in the last year.

LifeStance Health has an EPS (earnings per share) of $0.03.

See more trading valuation data for LifeStance Health
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$3B$3B3.0%3.0%24.6%53.7%$0.03

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

LifeStance Health Valuation Multiples

LifeStance Health trades at 2.2x EV/Revenue multiple, and 18.3x EV/EBITDA.

See NTM and 2027E valuation multiples for LifeStance Health

EV / Revenue (LTM)


LifeStance Health Financial Valuation Multiples

As of June 2, 2026, LifeStance Health has market cap of $3B and EV of $3B.

LifeStance Health has a P/E ratio of 102.4x.

LTMLast FY202320242025202620272028
EV/Revenue2.2x2.3x3.1x2.6x2.3x
EV/EBITDA18.3x20.9x(31.4x)82.7x41.8x
EV/EBIT66.1x136.5x(17.4x)(104.2x)136.5x
EV/Gross Profit6.6x7.1x10.9x8.2x7.1x
P/E102.4xn/m(16.3x)(52.8x)n/m
EV/FCF26.2x30.0x(57.4x)38.5x30.0x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified LifeStance Health Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

LifeStance Health Margins & Growth Rates

LifeStance Health grew revenue by 17% and EBITDA by 33% in the last fiscal year.

In the most recent fiscal year, LifeStance Health reported gross margin of 32%, EBITDA margin of 11%, and net margin of 1%.

See estimated margins and future growth rates for LifeStance Health

LifeStance Health Margins

Last FY202420252026202720282029
Gross Margin32%32%32%34%
EBITDA Margin11%3%6%13%
EBIT Margin2%(3%)2%5%
Net Margin1%(5%)1%3%
FCF Margin8%7%8%9%

LifeStance Health Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth17%19%14%17%
Gross Profit Growth21%33%15%21%
EBITDA Growth33%(138%)98%167%
EBIT Growth254%(83%)(176%)254%
Net Profit Growth492%(69%)(117%)492%
FCF Growth35%(249%)28%35%

Data powered by FactSet, Inc. and Morningstar, Inc.

LifeStance Health Operational KPIs

LifeStance Health's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

LifeStance Health's Rule of 40 is 29% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

LifeStance Health's Rule of X is 54% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for LifeStance Health
LTMLast FY202320242025202620272028
Rule of 4027%29%---
Bessemer Rule of X50%54%---
Revenue per Employee-$0.1M---
Opex per Employee-$0.0M---
G&A Expenses to Revenue25%27%39%29%27%
Opex to Revenue-31%47%35%31%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

LifeStance Health Competitors

LifeStance Health competitors include IKS Health, Krishna Institute, Dallah Healthcare, Option Care Health, Concentra Group, Meinian Onehealth, Global Health, Medicover, Asker Healthcare Group and Mouwasat.

Most LifeStance Health public comparables operate across Hospitals & Clinics.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
IKS Health8.6x8.1x25.0x24.8x
Krishna Institute8.8x8.4x41.8x40.5x
Dallah Healthcare4.5x3.4x19.3x16.9x
Option Care Health0.8x0.8x9.1x9.1x
Concentra Group2.4x2.4x12.3x11.8x
Meinian Onehealth2.5x2.4x11.8x13.2x
Global Health7.1x7.0x30.9x32.8x
Medicover1.8x1.7x10.9x10.4x

This data is available for Pro users. Sign up to see all LifeStance Health competitors and their valuation data.

Start Free Trial

LifeStance Health VC Funding History

Before going public, LifeStance Health raised $410M in total equity funding, across 2 rounds.


LifeStance Health Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
May-26Secondary - public-$285M-LifeStance Health Group, Inc. raised its full-year 2026 guidance in May 2026, reflecting continued strong growth in outpatient mental healthcare demand and operational execution. The company did not announce a new acquisition, investment, or valuation event in this period; the update was purely to its financial outlook. The revised 2026 guidance sets full-year revenue at $1.640 billion to $1.680 billion, implying a midpoint of $1.660 billion, up from the prior range of $1.615 billion to $1.655 billion. Adjusted EBITDA guidance was raised to $200 million to $220 million, with a midpoint of $210 million, indicating an Adjusted EBITDA margin of roughly 12.7% at the midpoint. Center Margin, a key internal profitability metric, is now expected to be $547 million to $571 million for the year. The company also expects second-quarter 2026 revenue of $405 million to $425 million, Center Margin of $135 million to $147 million, and Adjusted EBITDA of $50 million to $60 million. LifeStance operates as one of the largest providers of outpatient mental healthcare in the United States, delivering services through a network of clinics staffed by licensed clinicians. In the first quarter of 2026, revenue reached $403.5 million, up 21% year over year, driven by an 18% increase in visit volumes to 2.5 million and an 11% expansion of the clinician base to 8,349 clinicians. Center Margin in the quarter was $135.9 million, or 33.7% of revenue, while Adjusted EBITDA was $51.1 million, or 12.7% of revenue. The company generated $22.3 million of free cash flow in the quarter and ended with $194.8 million in cash and $262.5 million of net long-term debt, underscoring improving cash generation and leverage management.
May-24Secondary - public-$125M--

Acquisitions by LifeStance Health

LifeStance Health has acquired 1 company to date.

Last acquisition by LifeStance Health was on August 25th 2020. LifeStance Health acquired Edgewood Clinical Service for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by LifeStance Health

Edgewood Clinical Service
Description
Edgewood Clinical Service is a Minnesota-based provider of comprehensive psychological and mental health services, including therapy for anxiety, depression, trauma, and ADHD. The practice serves individuals, couples, families, and children through in-person and telehealth sessions at its locations in Maple Grove and Plymouth. Licensed clinicians offer evidence-based treatments like cognitive behavioral therapy and dialectical behavior therapy, with a focus on accessible care for diverse populations.
HQ CountryUnited States
HQ City
Chicago, IL
Deal Date25 Aug 2020
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all LifeStance Health acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About LifeStance Health

When was LifeStance Health founded?LifeStance Health was founded in 2021.
Where is LifeStance Health headquartered?LifeStance Health is headquartered in United States.
How many employees does LifeStance Health have?As of today, LifeStance Health has over 10K employees.
Who is the CEO of LifeStance Health?LifeStance Health's CEO is David P. Bourdon.
Is LifeStance Health publicly listed?Yes, LifeStance Health is a public company listed on Nasdaq.
What is the stock symbol of LifeStance Health?LifeStance Health trades under LFST ticker.
When did LifeStance Health go public?LifeStance Health went public in 2021.
Who are competitors of LifeStance Health?LifeStance Health main competitors include IKS Health, Krishna Institute, Dallah Healthcare, Option Care Health, Concentra Group, Meinian Onehealth, Global Health, Medicover, Asker Healthcare Group, Mouwasat.
What is the current market cap of LifeStance Health?LifeStance Health's current market cap is $3B.
What is the current revenue of LifeStance Health?LifeStance Health's last 12 months revenue is $2B.
What is the current revenue growth of LifeStance Health?LifeStance Health revenue growth (NTM/LTM) is 15%.
What is the current EV/Revenue multiple of LifeStance Health?Current revenue multiple of LifeStance Health is 2.2x.
What is the current EBITDA of LifeStance Health?LifeStance Health's last 12 months EBITDA is $180M.
What is LifeStance Health's EBITDA margin?LifeStance Health's last 12 months EBITDA margin is 12%.
What is the current EV/EBITDA multiple of LifeStance Health?Current EBITDA multiple of LifeStance Health is 18.3x.
What is the current FCF of LifeStance Health?LifeStance Health's last 12 months FCF is $126M.
What is LifeStance Health's FCF margin?LifeStance Health's last 12 months FCF margin is 8%.
What is the current EV/FCF multiple of LifeStance Health?Current FCF multiple of LifeStance Health is 26.2x.
How many companies LifeStance Health has acquired to date?As of June 2026, LifeStance Health has acquired 1 company.
What was the largest acquisition by LifeStance Health?None of the M&A deals LifeStance Health has completed have disclosed valuations.
What companies LifeStance Health acquired?LifeStance Health acquired Edgewood Clinical Service.
In how many companies LifeStance Health has invested to date?LifeStance Health hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to LifeStance Health

Lists including LifeStance Health

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial